BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30851209)

  • 1. Impact of voriconazole plasma concentrations on treatment response in critically ill patients.
    Ruiz J; Gordon M; Villarreal E; Peruccioni M; Marqués MR; Poveda-Andrés JL; Castellanos-Ortega Á; Ramirez P
    J Clin Pharm Ther; 2019 Aug; 44(4):572-578. PubMed ID: 30851209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.
    Vanstraelen K; Wauters J; Vercammen I; de Loor H; Maertens J; Lagrou K; Annaert P; Spriet I
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6782-9. PubMed ID: 25182655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics in China: The Dynamics of Intravenous Voriconazole in Critically Ill Patients with Pulmonary Disease.
    Chen W; Xie H; Liang F; Meng D; Rui J; Yin X; Zhang T; Xiao X; Cai S; Liu X; Li Y
    Biol Pharm Bull; 2015; 38(7):996-1004. PubMed ID: 26133710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
    Li H; Li M; Yan J; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Wang T; Zheng J; Qiang W; Zhang Y; Shi Q
    Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):495-504. PubMed ID: 32639669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Voriconazole-Associated Hepatotoxicity in Patients in the Intensive Care Unit.
    Wang Y; Wang T; Xie J; Yang Q; Zheng X; Dong W; Xing J; Wang X; Dong Y
    Pharmacotherapy; 2016 Jul; 36(7):757-65. PubMed ID: 27284960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit.
    Lin XB; Huang F; Tong L; Xia YZ; Wu JJ; Li J; Hu XG; Liang T; Liu XM; Zhong GP; Cai CJ; Chen X
    Int J Infect Dis; 2020 Apr; 93():345-352. PubMed ID: 32109625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.
    Vanstraelen K; Maertens J; Augustijns P; Lagrou K; de Loor H; Mols R; Annaert P; Malfroot A; Spriet I
    Clin Pharmacokinet; 2015 Nov; 54(11):1151-60. PubMed ID: 25910879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
    Kiser TH; Fish DN; Aquilante CL; Rower JE; Wempe MF; MacLaren R; Teitelbaum I
    Crit Care; 2015 Feb; 19(1):32. PubMed ID: 25645660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of different pharmacokinetic models to describe and predict pharmacokinetics of voriconazole in magellanic penguins following oral administration.
    Parsley RA; Mutlow AG; Hansted J; Taverne FJ; Tell LA; Gehring R
    J Vet Pharmacol Ther; 2019 Jan; 42(1):74-84. PubMed ID: 30175535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Drug Monitoring of Voriconazole in Critically Ill Pediatric Patients: A Single-Center Retrospective Study.
    Taher KW; Almofada R; Alomair S; Albassam AA; Alsultan A
    Paediatr Drugs; 2024 Mar; 26(2):197-203. PubMed ID: 38228969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between voriconazole exposure and Sequential Organ Failure Assessment (SOFA) score in critically ill patients.
    Bienvenu AL; Pradat P; Plesa A; Leclerc V; Piriou V; Fellahi JL; Argaud L; Rimmelé T; Menotti J; Aubrun F; Richard JC; Gagnieu MC; Parant F; Chidiac C; Leboucher G; Tod M; Goutelle S
    PLoS One; 2021; 16(11):e0260656. PubMed ID: 34818379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of voriconazole in critically ill patients with invasive mycoses].
    Alvarez Lerma F
    Rev Iberoam Micol; 2007 Sep; 24(3):209-12. PubMed ID: 17874857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients.
    Sime FB; Byrne CJ; Parker S; Stuart J; Butler J; Starr T; Pandey S; Wallis SC; Lipman J; Roberts JA
    Crit Care; 2019 Jun; 23(1):205. PubMed ID: 31171022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
    Myrianthefs P; Markantonis SL; Evaggelopoulou P; Despotelis S; Evodia E; Panidis D; Baltopoulos G
    Int J Antimicrob Agents; 2010 May; 35(5):468-72. PubMed ID: 20188523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturated Metabolism of Voriconazole N-Oxidation Resulting in Nonlinearity of Pharmacokinetics of Voriconazole at Clinical Doses.
    Yamada T; Mino Y; Yagi T; Naito T; Kawakami J
    Biol Pharm Bull; 2015; 38(10):1496-503. PubMed ID: 26424015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Diarrhea Influence Plasma Voriconazole Concentration?
    Nakayama H; Usuki K; Hanada K; Orii T; Kato T
    Ther Drug Monit; 2020 Apr; 42(2):341-344. PubMed ID: 31972774
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of total and free voriconazole in human plasma: Application to pharmacokinetic study and therapeutic monitoring.
    Resztak M; Kosicka K; Zalewska P; Krawiec J; Główka FK
    J Pharm Biomed Anal; 2020 Jan; 178():112952. PubMed ID: 31708268
    [No Abstract]   [Full Text] [Related]  

  • 18. Voriconazole Therapeutic Drug Monitoring Practices in Intensive Care.
    van Wanrooy MJ; Rodgers MG; Span LF; Zijlstra JG; Uges DR; Kosterink JG; van der Werf TS; Alffenaar JW
    Ther Drug Monit; 2016 Jun; 38(3):313-8. PubMed ID: 26845112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment.
    Kim SH; Kwon JC; Park C; Han S; Yim DS; Choi JK; Cho SY; Lee HJ; Park SH; Choi SM; Choi JH; Yoo JH; Lee DG; Lee JW
    Mycoses; 2016 Oct; 59(10):644-51. PubMed ID: 27324913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
    Alvarez-Lerma F; Nicolás-Arfelis JM; Rodríguez-Borregán JC; Díaz-Regañón J; Sa-Borges M; García-López F; Allepuz-Palau A
    J Chemother; 2005 Aug; 17(4):417-27. PubMed ID: 16167522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.